Finance

Lists
NATCOPHARM:NSE
Natco Pharma
၇၈၂.၅၀ ₹
-၀.၈၄%
(-၆.၆၅) 1D
အောက် ၁၄, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NATCOPHARM...
Open
၇၈၉.၁၅ ₹
High
၇၉၄.၀၀ ₹
Low
၇၈၁.၀၀ ₹
Mkt. cap
ဋေ ၁.၄၀ သ
Avg. vol.
၄.၄၀ သိန်း
Volume
၄.၆၅ သိန်း
Dividend
၀.၅၇%
Quarterly dividend
၁.၁၂ ₹
Ex-dividend date
၂၀၂၆ ဩ ၂၀
P/E ratio
၁၂.၃၅
52-wk high
၁,၂၁၆.၈၉ ₹
52-wk low
၇၈၁.၀၀ ₹
EPS
၆၃.၃၇ ₹
Shares outstanding
၁၈.၂၃ ကုဋေ
No. of employees
၄ ထောင်
Open
၇၈၉.၁၅ ₹
High
၇၉၄.၀၀ ₹
Low
၇၈၁.၀၀ ₹
Mkt. cap
ဋေ ၁.၄၀ သ
Avg. vol.
၄.၄၀ သိန်း
Volume
၄.၆၅ သိန်း
Dividend
၀.၅၇%
Quarterly dividend
၁.၁၂ ₹
Ex-dividend date
၂၀၂၆ ဩ ၂၀
P/E ratio
၁၂.၃၅
52-wk high
၁,၂၁၆.၈၉ ₹
52-wk low
၇၈၁.၀၀ ₹
EPS
၆၃.၃၇ ₹
Shares outstanding
၁၈.၂၃ ကုဋေ
No. of employees
၄ ထောင်
News stories
From web sources and news partners
Local 3 News
Local 3 News
·
ပြီးခဲ့သည့် ၅၄ မိနစ်
RAW: NYSE: OPENING BELL (WEDNESDAY)
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၄ မိနစ်
Will Phase 3 Trial Data Change Amylyx Pharmaceuticals Stock Narrative
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃၂ မိနစ်
This ETF Has Crushed the S&P 500 in 2026. Here's Why I Think It Still Has Room to Grow.
TradingView
TradingView
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
Rising consumer prices, oil and treasury yields send S&P 500, Nasdaq lower
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma
CEORajeev Nannapaneni
Employees၄.၄၃ ထောင်
Founded၁၉၈၁
HeadquartersBanjara Hills, တယ်လန်ဂါနာ, အိန္ဒိယ
Sector-
Last report
၂၀၂၆ ဩ ၁၄
Fiscal period
Q1 2027
၁၁.၅၃ ₹ / ၈.၈၆ ₹
+၃၀.၀၆%beat
Revenue / Est. (INR)
၇၃၅.၂၀ ဋေ / ၇၉၆.၂၀ ဋေ
-၇.၆၆%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၃၆ ထ
၆၄၇.၃၀ ဋေ
၇၄၂.၆၀ ဋေ
၇၃၅.၂၀ ဋေ
Cost of goods sold
၁၆၉.၇၀ ဋေ
၁၃၃.၁၀ ဋေ
၁၉၉.၂၀ ဋေ
၁၄၇.၅၀ ဋေ
Cost of revenue
၁၆၉.၇၀ ဋေ
၁၃၃.၁၀ ဋေ
၁၉၉.၂၀ ဋေ
၁၄၇.၅၀ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၀၀.၃၀ ဋေ
၁၅၉.၄၀ ဋေ
၁၆၃.၂၀ ဋေ
၁၇၉.၃၀ ဋေ
Operating expense
၆၆၆.၅၀ ဋေ
၄၀၁.၇၀ ဋေ
၄၃၇.၆၀ ဋေ
၄၄၈.၃၀ ဋေ
Total operating expenses
၈၃၆.၂၀ ဋေ
၅၃၄.၈၀ ဋေ
၆၃၆.၈၀ ဋေ
၅၉၅.၈၀ ဋေ
Operating income
၅၂၆.၈၀ ဋေ
၁၁၂.၅၀ ဋေ
၁၀၅.၈၀ ဋေ
၁၃၉.၄၀ ဋေ
Other non operating income
၁၀၀.၀၀ ဋေ
၅၈.၁၀ ကုဋေ
-၂၁၁.၁၀ ဋေ
၅၉.၂၀ ကုဋေ
EBT including unusual items
၆၁၃.၇၀ ဋေ
၁၇၂.၀၀ ဋေ
၁၇၉.၈၀ ဋေ
၂၆၉.၉၀ ဋေ
EBT excluding unusual items
၆၁၃.၇၀ ဋေ
၁၇၂.၀၀ ဋေ
၂၀၂.၄၀ ဋေ
၂၆၉.၉၀ ဋေ
Income tax expense
၉၅.၈၀ ကုဋေ
၂၀.၇၀ ကုဋေ
-၈၉.၂၀ ကုဋေ
၆၃.၄၀ ကုဋေ
Effective tax rate
၁၅.၆၁%
၁၂.၀၃%
-၄၉.၆၁%
၂၃.၄၉%
Other operating expenses
၄၁၃.၈၀ ဋေ
၁၉၆.၁၀ ဋေ
၂၂၂.၉၀ ဋေ
၂၂၁.၉၀ ဋေ
Net income
၅၁၈.၄၀ ဋေ
၁၅၁.၅၀ ဋေ
၂၆၇.၉၀ ဋေ
၂၀၆.၅၀ ဋေ
Net profit margin
၃၈.၀၃%
၂၃.၄၀%
၃၆.၀၈%
၂၈.၀၉%
Earnings per share
၂၈.၉၄
၈.၄၆
၁၄.၉၆
၁၁.၅၃
Interest and investment income
-
-
၂၃၂.၉၀ ဋေ
-
Interest expense
-၁၃.၁၀ ကုဋေ
-၉.၅၀ ကုဋေ
-
-၁၃.၀၀ ကုဋေ
Net interest expenses
-၁၃.၁၀ ကုဋေ
-၉.၅၀ ကုဋေ
၂၃၂.၉၀ ဋေ
-၁၃.၀၀ ကုဋေ
Depreciation and amortization charges
၅၂.၄၀ ကုဋေ
၄၆.၂၀ ကုဋေ
၅၀.၄၀ ကုဋေ
၄၇.၁၀ ကုဋေ
EBITDA
၅၈၁.၈၀ ဋေ
၁၅၇.၀၀ ဋေ
၁၅၅.၂၅ ဋေ
၁၉၁.၀၅ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ